Nanoparticles for cellular drug delivery: Mechanisms and factors influencing delivery

被引:137
作者
Chavanpatil, Mahesh D.
Khdair, Ayman
Panyam, Jayanth [1 ]
机构
[1] Wayne State Univ, Dept Pharmaceut Sci, Eugene Applebaum Coll Pharm & Hlth Sci, Detroit, MI 48201 USA
[2] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA
关键词
gene delivery; endocytosis; receptors; ligands; antibodies; trafficking;
D O I
10.1166/jnn.2006.443
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Polymeric nanoparticles have demonstrated enormous potential as cellular drug delivery vehicles. Nanoparticles improve drug's stability as well as its availability and retention at the target intracellular site of action. Therapeutic efficacy of nanoparticles can be further enhanced by conjugating specific ligands to nanoparticle surface. Ligand conjugation can also be used to favorably modify the intracellular disposition of nanoparticles. A number of ligands are available for this purpose; use of a specific ligand depends on the target cell, the material used for nanoparticle formulation, and the chemistry available for ligand-nanoparticle conjugation. Cellular drug delivery using nanoparticles is also affected by clearance through the reticuloendothelial system. In this paper, we review the recent progress on our understanding of physicochemical factors that affect the cellular uptake of nanoparticles and the different cellular processes that could be exploited to enhance nanoparticle uptake into cells.
引用
收藏
页码:2651 / 2663
页数:13
相关论文
共 117 条
[1]   An overview of targeted treatments in cancer [J].
Abou-Jawde, R ;
Choueiri, T ;
Alemany, C ;
Mekhail, T .
CLINICAL THERAPEUTICS, 2003, 25 (08) :2121-2137
[2]   Recent advances on chitosan-based micro- and nanoparticles in drug delivery [J].
Agnihotri, SA ;
Mallikarjuna, NN ;
Aminabhavi, TM .
JOURNAL OF CONTROLLED RELEASE, 2004, 100 (01) :5-28
[3]   Antisense oligonucleotide delivery to cultured macrophages is improved by incorporation into sustained-release biodegradable polymer microspheres [J].
Akhtar, S ;
Lewis, KJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 151 (01) :57-67
[4]   Iron homeostasis: Insights from genetics and animal models [J].
Andrews, NC .
NATURE REVIEWS GENETICS, 2000, 1 (03) :208-217
[5]   Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia [J].
Aplenc, R ;
Thompson, J ;
Han, P ;
La, M ;
Zhao, HQ ;
Lange, B ;
Rebbeck, T .
CANCER RESEARCH, 2005, 65 (06) :2482-2487
[6]   Influence of the surfactant concentration on the body distribution of nanoparticles [J].
Araujo, L ;
Löbenberg, R ;
Kreuter, J .
JOURNAL OF DRUG TARGETING, 1999, 6 (05) :373-385
[7]   REACTIONS OF NORMAL AND TUMOR CELL SURFACES TO ENZYMES, .1. WHEAT-GERM LIPASE AND ASSOCIATED MUCOPOLYSACCHARIDES [J].
AUB, JC ;
LANKESTER, A ;
TIESLAU, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1963, 50 (04) :613-&
[8]  
AZARI PR, 1958, J BIOL CHEM, V232, P293
[9]   PLGA nanoparticles in drug delivery: The state of the art [J].
Bala, I ;
Hariharan, S ;
Kumar, MNVR .
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2004, 21 (05) :387-422
[10]   Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles [J].
Banerjee, T ;
Mitra, S ;
Singh, AK ;
Sharma, RK ;
Maitra, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 243 (1-2) :93-105